+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Coagulation & Hemostasis Testing Market by Test Type (Activated Partial Thromboplastin Time, D-Dimer Testing, Fibrinogen Testing), Technology (Electrochemical Technology, Mechanical Technology, Optical Technology), End-Use - Forecast 2024-2030- Product Image
Global Coagulation & Hemostasis Testing Market by Test Type (Activated Partial Thromboplastin Time, D-Dimer Testing, Fibrinogen Testing), Technology (Electrochemical Technology, Mechanical Technology, Optical Technology), End-Use - Forecast 2024-2030- Product Image
Sale

Global Coagulation & Hemostasis Testing Market by Test Type (Activated Partial Thromboplastin Time, D-Dimer Testing, Fibrinogen Testing), Technology (Electrochemical Technology, Mechanical Technology, Optical Technology), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 197 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5456914
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Coagulation & Hemostasis Testing Market size was estimated at USD 5.29 billion in 2023, USD 5.88 billion in 2024, and is expected to grow at a CAGR of 11.28% to reach USD 11.18 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Coagulation & Hemostasis Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Coagulation & Hemostasis Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Coagulation & Hemostasis Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Danaher Corporation, Diagnostica Stago SAS, F. Hoffmann-La Roche Ltd., George King Bio-Medical, Inc., Grifols, S.A., Helena Laboratories Corporation, Medtronic PLC, Micropoint Biotechnologies Co., Ltd, Sekisui Chemical Co., Ltd., Siemens AG, Sysmex Corporation, Tcoag Ireland Limited, Thermo Fisher Scientific Inc., and Werfen, S.A.

Market Segmentation & Coverage

This research report categorizes the Coagulation & Hemostasis Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test Type
    • Activated Partial Thromboplastin Time
    • D-Dimer Testing
    • Fibrinogen Testing
    • Platelet Function Tests
  • Technology
    • Electrochemical Technology
    • Mechanical Technology
    • Optical Technology
  • End-Use
    • Diagnostic Centers
    • Hospitals
    • Point-of-Care Testing
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Coagulation & Hemostasis Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Coagulation & Hemostasis Testing Market?
  3. What are the technology trends and regulatory frameworks in the Coagulation & Hemostasis Testing Market?
  4. What is the market share of the leading vendors in the Coagulation & Hemostasis Testing Market?
  5. Which modes and strategic moves are suitable for entering the Coagulation & Hemostasis Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Coagulation & Hemostasis Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the Prevalence of cardiovascular diseases and blood disorders globally
5.1.1.2. Increasing adoption of automated hemostasis equipment in diagnostic laboratories
5.1.1.3. Availability of government initiatives focusing on awareness of hemophilia
5.1.2. Restraints
5.1.2.1. High cost associated with fully automated coagulation systems
5.1.3. Opportunities
5.1.3.1. Rising demand for point of care (POC) coagulation testing
5.1.3.2. Technological advancements in coagulation & hemostasis testing
5.1.4. Challenges
5.1.4.1. Stringent and time-consuming regulatory processes
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Coagulation & Hemostasis Testing Market, by Test Type
6.1. Introduction
6.2. Activated Partial Thromboplastin Time
6.3. D-Dimer Testing
6.4. Fibrinogen Testing
6.5. Platelet Function Tests
7. Coagulation & Hemostasis Testing Market, by Technology
7.1. Introduction
7.2. Electrochemical Technology
7.3. Mechanical Technology
7.4. Optical Technology
8. Coagulation & Hemostasis Testing Market, by End-Use
8.1. Introduction
8.2. Diagnostic Centers
8.3. Hospitals
8.4. Point-of-Care Testing
9. Americas Coagulation & Hemostasis Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Coagulation & Hemostasis Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Coagulation & Hemostasis Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Danaher Corporation
13.1.3. Diagnostica Stago SAS
13.1.4. F. Hoffmann-La Roche Ltd.
13.1.5. George King Bio-Medical, Inc.
13.1.6. Grifols, S.A.
13.1.7. Helena Laboratories Corporation
13.1.8. Medtronic PLC
13.1.9. Micropoint Biotechnologies Co., Ltd
13.1.10. Sekisui Chemical Co., Ltd.
13.1.11. Siemens AG
13.1.12. Sysmex Corporation
13.1.13. Tcoag Ireland Limited
13.1.14. Thermo Fisher Scientific Inc.
13.1.15. Werfen, S.A.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. COAGULATION & HEMOSTASIS TESTING MARKET RESEARCH PROCESS
FIGURE 2. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COAGULATION & HEMOSTASIS TESTING MARKET DYNAMICS
FIGURE 7. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 8. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. COAGULATION & HEMOSTASIS TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. COAGULATION & HEMOSTASIS TESTING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. COAGULATION & HEMOSTASIS TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 6. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY D-DIMER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY FIBRINOGEN TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY PLATELET FUNCTION TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY MECHANICAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY OPTICAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 15. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 28. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. CANADA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. MEXICO COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 45. CHINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. CHINA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. INDIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. INDIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. JAPAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. THAILAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. EGYPT COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. FINLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. FRANCE COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. GERMANY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. ITALY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. NORWAY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. POLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. POLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. QATAR COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. SPAIN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. TURKEY COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM COAGULATION & HEMOSTASIS TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. COAGULATION & HEMOSTASIS TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 146. COAGULATION & HEMOSTASIS TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. COAGULATION & HEMOSTASIS TESTING MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Danaher Corporation
  • Diagnostica Stago SAS
  • F. Hoffmann-La Roche Ltd.
  • George King Bio-Medical, Inc.
  • Grifols, S.A.
  • Helena Laboratories Corporation
  • Medtronic PLC
  • Micropoint Biotechnologies Co., Ltd
  • Sekisui Chemical Co., Ltd.
  • Siemens AG
  • Sysmex Corporation
  • Tcoag Ireland Limited
  • Thermo Fisher Scientific Inc.
  • Werfen, S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.88 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.18 Billion
Compound Annual Growth Rate11.2%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Coagulation Analyzer Market - Forecasts from 2024 to 2029 - Product Image

Coagulation Analyzer Market - Forecasts from 2024 to 2029

  • Report
  • 145 Pages
  • Global
From
Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 - Product Image

Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

  • Report
  • Global
From
Thrombosis And Hemostasis Biomarkers Market Size, Share & Trends Analysis Report By Product (Analyzers, Reagents & Consumables), By Test Location, By Test Type, By Application, By End-use, By Region, And Segment Forecasts, 2023-2030 - Product Image

Thrombosis And Hemostasis Biomarkers Market Size, Share & Trends Analysis Report By Product (Analyzers, Reagents & Consumables), By Test Location, By Test Type, By Application, By End-use, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 180 Pages
  • Global
From
2024 World Coagulation Testing Market in 98 Countries - Hemostasis Analyzers and Consumables - Supplier Shares, 2023-2028 - Product Image

2024 World Coagulation Testing Market in 98 Countries - Hemostasis Analyzers and Consumables - Supplier Shares, 2023-2028

  • Report
  • Global
From
Hemostasis Diagnostic Devices And Equipment Global Market Report 2024 - Product Image

Hemostasis Diagnostic Devices And Equipment Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.